Title

Earning Preview: HealthEquity this quarter’s revenue is expected to increase by 8.78%, and institutional views are bullish

Abstract

HealthEquity is scheduled to report results on March 17, 2026, Post Market; this preview outlines a revenue outlook of 332.91 million USD (+8.78% YoY), projected EPS of 0.90 (+25.24% YoY), and the key segment drivers and margin dynamics investors are watching this quarter.

Market Forecast

The current quarter outlook points to revenue of 332.91 million USD, implying 8.78% year-over-year growth, alongside an EPS estimate of 0.90, representing 25.24% year-over-year growth; EBIT is projected at 66.84 million USD (+40.04% YoY). Margin guidance has not been provided, so investors will reference recent levels to gauge trajectory. Within the company’s revenue base, custodial (159.07 million USD last quarter), service (120.29 million USD), and interchange (42.81 million USD) collectively remain the core drivers; the mix suggests a heavy earnings contribution from interest-bearing HSA cash and fee-based services, with stability expected near term. The most promising near-term contributor continues to be custodial yield-driven revenue (159.07 million USD last quarter), as the overall top line is forecast to grow 8.78% YoY on sustained HSA asset balances; the company’s interest capture and member growth form the basis of the upswing.

Last Quarter Review

HealthEquity delivered revenue of 322.16 million USD (+7.23% YoY), a gross profit margin of 70.79%, GAAP net income attributable to shareholders of 51.69 million USD (net margin 16.05%), and adjusted EPS of 1.01 (+29.49% YoY). A standout was operating performance: EBIT of 78.70 million USD grew 300.99% year over year and exceeded the prior estimate modestly, while sequential net income declined by 13.64%, indicating some quarter-to-quarter variability within otherwise expanding profitability. By business line, custodial revenue was 159.07 million USD (49.37% of total), service revenue reached 120.29 million USD (37.34%), and interchange revenue was 42.81 million USD (13.29%), reflecting a mix supportive of premium gross margins and scalable operating leverage as accounts and assets continue to rise.

Current Quarter Outlook (with major analytical insights)

Main business: HSA-driven custodial, service, and interchange revenue

HealthEquity’s financial framework remains anchored in three complementary revenue streams: custodial revenue earned on HSA cash and investments, service fees tied to account administration, and interchange income from HSA-linked debit card spend. With the company guiding to a 332.91 million USD revenue estimate (+8.78% YoY) and 0.90 in EPS (+25.24% YoY), the near-term picture implies continued healthy demand for tax-advantaged health savings accounts (HSAs) and steady utilization by members. The 70.79% gross margin achieved last quarter offers a high-quality baseline entering the print; while the company hasn’t issued explicit margin targets for the quarter, the revenue mix continues to favor custodial yields and fee-based stability, supporting profitability consistency. The recent net margin of 16.05% shows leverage potential as operating expense growth tracks below revenue growth; sustaining this requires both retention of high-value accounts and prudent expense discipline in servicing and technology.

Interpreting last quarter’s results provides a practical bridge to this quarter. Revenue growth of 7.23% YoY last quarter and adjusted EPS growth of 29.49% YoY suggest that operating leverage is accelerating as scale and cash yields compound. Notably, EBIT growth of 300.99% YoY last quarter was extraordinary and likely reflects cycling of prior-year factors alongside effective yield capture; it should not be extrapolated linearly, but it underscores the earnings sensitivity to top-line mix and rate exposure. For the current quarter, the model-implied path—revenue up 8.78% YoY and EPS up 25.24% YoY—would be consistent with strong fee and yield trends, provided spend patterns and account growth remain solid through the benefits year transition period.

Most promising business: Custodial yield and HSA cash economics

Custodial revenue, which totaled 159.07 million USD last quarter, remains the highest-impact lever on earnings. The estimate for EBIT growth (+40.04% YoY) suggests continued strength in net interest spread capture, with deposit returns enhanced by the sustained rate environment and thoughtful portfolio positioning. A stabilizing backdrop for short-duration instruments supports the net yield on HSA cash, while the company’s strategic allocation of custodial assets provides some flexibility to navigate curve shifts. In this context, even modest growth in average HSA cash balances can translate to outsize EBIT and EPS advances when spreads remain constructive.

The growth durability of custodial economics hinges on two controllable engines: net new HSA accounts and average cash per account. Account growth typically reflects new employer wins and better enrollment penetration, while average balances correlate with health care cost trends and member behavior. If the company continues to register above-average HSA adoption and maintains engagement strategies that encourage recurring contributions, custodial revenue can outperform broader top-line growth. Analysts describing “above-consensus HSA growth” frame the custodial stream as a reliable compounder; the forward view embeds that revenue growth will at least pace the 8.78% YoY top-line estimate, with upside if balances or yields surprise positively.

Stock-price swing factors: Rate path, spend intensity, and operating leverage

The interest rate path remains the dominant short-cycle variable for earnings translation. While the company does not provide explicit quarterly gross or net margin forecasts, last quarter’s 70.79% gross margin and 16.05% net margin indicate a stable platform. If front-end rates remain near recent levels through the quarter, custodial yields should hold in a supportive range, preserving the spread needed to lift EPS to the 0.90 estimate (+25.24% YoY). Any unexpected drop in front-end yields would compress the spread more quickly than fee revenue can offset, potentially deflating EBIT from the 66.84 million USD estimate.

Debit card spend intensity and seasonality can also move the needle. Interchange revenue of 42.81 million USD last quarter reflects steady member activity; quarter-to-quarter, spend can vary with the cadence of annual deductibles and claims, especially early in benefits cycles. The ability to encourage card-based payments for eligible expenses, alongside seamless digital experiences, influences both interchange and service fees. If the company sustains card adoption and drives higher transaction counts per member, interchange growth can positively skew revenue, even if custodial yields plateau. Conversely, a lull in transactions could temper upside.

Operating leverage is the third pivot. Last quarter’s sharply higher EBIT (+300.99% YoY) underlines sensitivity to fixed-cost absorption and variable cost management. For the upcoming print, a revenue step-up to 332.91 million USD (+8.78% YoY) combined with disciplined expense growth could keep adjusted EPS tracking toward the 0.90 mark. Should customer support, implementation, or technology costs spike ahead of revenue, margin expansion would slow. Investors will also watch for commentary on cost trajectories within service operations and any scaling efficiencies that could inform the next fiscal year.

Analyst Opinions

The balance of recently published opinions is decisively bullish, with the ratio of bullish to bearish views at 100% to 0%. Multiple institutions reiterate Buy ratings and articulate a constructive framework around HSA growth, custodial yields, and valuation, even as one firm trimmed its price target. The collective message emphasizes upside risk to earnings if HSA account additions and cash balances remain robust through the quarter and if the rate environment stays supportive for spread income.

KeyBanc reaffirmed a Buy rating and a 125.00 USD price target, signaling confidence that account growth and yields can deliver results in line with or ahead of the 8.78% YoY revenue estimate and the 0.90 EPS projection. The firm’s perspective implicitly leans on the durability of HealthEquity’s fee base and the runway for custodial economics to sustain above-trend EBIT growth. In their framework, the valuation remains reasonable against mid-20% EPS expansion, particularly with the company’s revenue mix skewing toward high-quality recurring streams.

Wells Fargo also maintained a Buy with a 125.00 USD target, reinforcing the view that the stock’s risk-reward remains attractive into the print. Their stance aligns with the idea that earnings visibility is adequate despite near-term uncertainties around interest rates and spend seasonality. The bank’s outlook suggests confidence that the company can execute against the 66.84 million USD EBIT estimate (+40.04% YoY), which would support a robust year-on-year EPS cadence and potentially catalyze positive estimate revisions if operating leverage continues to materialize.

Bank of America highlighted “Above-Consensus HSA Growth and Cautious Valuation Support Buy Rating,” also pointing to a 125.00 USD target. This view stresses that structural HSA expansion serves as a multi-year driver underpinning both service fee and custodial revenue rises. In the near term, their framing implies that even modest upside to HSA account growth or balances could translate to meaningful EPS outperformance relative to the 0.90 estimate, given the operating model’s sensitivity to custodial yields.

Jefferies maintained a Buy rating while lowering its price target to 108.00 USD from 120.00 USD, which provides a helpful counterbalance within the bullish cohort. The trim acknowledges valuation recalibration and potentially more conservative custodial yield assumptions but does not alter the constructive stance into the quarter. Jefferies’ maintained Buy indicates they still see sufficient drivers—HSA membership growth, stable fee income, and manageable expense scaling—to back the case for mid- to high-single-digit revenue growth and low- to mid-20% EPS growth in the near term, consistent with the 8.78% and 25.24% YoY prints currently embedded in estimates.

Synthesizing these perspectives, the majority view anticipates a results set that aligns with or beats the top-line forecast of 332.91 million USD and reconfirms the path toward mid-20% EPS growth. Analysts focus on several confirmation points for the call and outlook: evidence of sustained HSA account additions, commentary on average HSA cash balances, qualitative color on rate sensitivity of custodial yields, and indications that operating costs remain disciplined enough to translate revenue growth into incremental margin. If management communicates that yield capture remains resilient and that HSA adoption is tracking above plan, the bullish case strengthens with room for the shares to rerate toward the 108.00–125.00 USD target range cited across the banks.

In terms of positioning ahead of March 17, 2026, Post Market, the bullish camp appears comfortable that the company’s model can deliver on the 66.84 million USD EBIT estimate and 0.90 EPS projection without aggressive assumptions. The most likely swing variable in their assessment is not member demand—seen as steady to improving—but rather the path of short-term rates and the company’s custodial asset allocation choices. Given the last quarter’s 70.79% gross margin and 16.05% net margin, the street expects profitability to remain robust, even if sequential variations continue. Should the print demonstrate that the revenue mix continues to favor custodial and fee streams, and that cash yields are being prudently managed, the consensus bullish stance is likely to persist through the early spring reporting cycle.

Overall, the preponderance of recent analyst commentary points to a constructive setup. Revenue growth of 8.78% YoY appears well-supported by structural HSA trends, while EPS growth of 25.24% YoY seems attainable with steady spreads and operating leverage. The stocks’ Buy ratings and targets clustered between 108.00 USD and 125.00 USD reflect confidence in the medium-term earnings trajectory and a view that the current valuation fairly discounts execution risk while leaving upside if tailwinds hold. Investors will look for confirmation that custodial revenue remains the primary earnings engine and that service and interchange maintain their steady contributions, rounding out a balanced, margin-accretive revenue mix for the quarter at hand.